Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc. > Tilray dropped the ball a bit. A miss IMO.

<< Previous

Bullboard Posts

Next >>

Comment by hevinon Aug 10, 2020 4:16pm

153 Views

Post# 31389372

RE:Tilray dropped the ball a bit. A miss IMO.

Looks more like a proper s-hitting of the bed to me. Apha looks great in comparison. I'm sure our sp will be illogically punished for a day or so because of tilrays results. Such is investing. But then we gradually keep going up.

Daredevil1964 wrote: https://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200810:nBw8fKS7za

Revenue Increased 10% to $50.4 Million (C$69.4 Million) versus Q2 2019

Cost Savings of $13.0 Million Realized in Q2 2020 – on Pace for Total Annualized Savings of Approximately $55 Million

Net Loss of ($81.7) Million increased $45.4 Million versus Q2 2019 Partially Due to Facilities Closure and Inventory Adjustments

Adjusted EBITDA Loss of ($12.3) Million Represents 32% Improvement compared to both Q2 2019 and Q1 2020

$137 Million Q2 2020 Ending Cash Balance and $250 Million Remaining on ATM